Combined Pten-p53 mutationsaccelerated formation of claudin-low, triple-negative-like breast cancer (TNBC) that exhibitedhyper-activated AKT signaling and more mesenchymal features relative to Pten or p53 single-mutanttumors. The gene discussed is TP53; the disease is breast cancer.